Women’s Health Update – 24 Jun 2026: Dostarlimab 6-Year Data, Nivi–MSD HPV Initiative and More

Neuroscience Update – 24 Jun 2026: Cenrifki EU Approval, Ambelvist FDA Approval and More

ARTIFICIAL INTELLIGENCE and DIGITAL HEALTH Update – 23 Jun 2026: NHS AI Rollout, OpenAI IPOs & more

Obesity Update – 23 Jun 2026: Oral Obesity-Pill Race, China Oral Wegovy Filing and More

Oncology Update – 22 Jun 2026: Ozekibart BLA Accepted, J&J Acquires Firefly Bio and More

Public Health Update – 19 June 2026: NIH ORIVA human-based methods, air pollution coronary plaque

Rare Diseases Update – 18 Jun 2026: HYMPAVZI FDA Expansion, LOJUXTA Pediatric Approval and More

Cardiovascular Update – 18 Jun 2026: Triformis Resilia and Thunderbolt FDA Clearance and More

Immunology Update – 17 Jun 2026: Ultomiris Priority Review in IgAN, Cosentyx PMR Data and More

Endocrinology Update – 16 Jun 2026: Tandem Control-IQ+ CE Mark Expansion, Korlym Data and More

Hematology Update – 15 Jun 2026: Opdivo EU Approval, Scemblix CML Data and More

Vaccines Research – 11 Jun 2026: CEPI Bundibugyo Ebola vaccine, Moderna–Merck melanoma data and More

Respiratory Research Update – 12 June 2026: RSV, ARDS, ILD Imaging and More

Gene and Cell Therapy Update – 11 Jun 2026: FDA guidance, China approval and More

Women's Health Update – 10 Jun 2026: Giredestrant, Iza-bren and More

Neuroscience Update – 10 Jun 2026: Vyepti approved in South Korea, Aquipta EU approval & More

Obesity Update – 9 Jun 2026: Survodutide Phase 3 Data, Wegovy Pill Tops 3M Prescriptions and More

Oncology Update – 8 Jun 2026: Imfinzi FDA Approval, Zepzelca EU Approval and More

Public Health Update – 5 Jun 2026: Immunization Agenda 2030, Pancreatic Cancer Data and More

Rare Diseases Update – 4 Jun 2026: PYRUKYND EU Approval, Venglustat FDA Priority Review and More

Cardiovascular Update – 4 Jun 2026: MYQORZO Launch, ACIST Clearance and More

Immunology Update – 3 Jun 2026: Imfinzi Approval, Tremfya Label Expansion and More

Endocrinology Update – 2 Jun 2026: Kerendia Priority Review, Control-IQ+ Clearance and More

Hematology Update – 1 Jun 2026: HEMGENIX Canada Access, VENCLYXTO EU Expansion and More

Vaccine Research Update – 29 May 2026: GSK Arexvy Japan expansion, Pfizer 25-valent PCV and More

Respiratory Research Update – 29 May 2026: JASCAYD Japan Approval, BEAM-302 AATD Data and More

Gene and Cell Therapy Update – 28 May 2026: Vyjuvek UK Approval, RGX-202 Phase 3 and More

Women’s Health Update – 27 May 2026: Enhertu Expansion, Datroway Approval and More

Neuroscience Update – 27 May 2026: TEV-749 EMA Acceptance, BIIB122 Miss and More

ARTIFICIAL INTELLIGENCE and DIGITAL HEALTH Update – 26 May 2026: EU AI Screening Push and More

Obesity Update – 26 May 2026: Lilly Retatrutide, Vincentage VCT220 and More

Oncology Update – 25 May 2026: Enhertu Breast Cancer Approval, Datroway TNBC and More

Public Health Update – 22 May 2026: WHO warns SDG setback risk, fabricated citations surge and More

Cardiovascular Update – 21 May 2026: Baxfendy Approval, Asundexian NDAs and More

Rare Diseases Update – 21 May 2026: HYMPAVZI EU Approval, Angelini-Catalyst Deal and More

Immunology Update – 20 May 2026: Sotyktu EU Approval, Mabwell FDA IND and More

Endocrinology Update – 19 May 2026: Sandoz Insulin Biosimilars, Sogroya Korea and More

Hematology Update – 18 May 2026: INQOVI AML FDA Approval, HYMPAVZI EU Expansion and More

Vaccines Update – 15 May 2026: Moderna Phase 3 flu efficacy, maternal Tdap meta-analysis and More

Respiratory Research Update – 15 May 2026: MD-712 Filing, CXG87 NDA and More

Gene and Cell Therapy Update – 14 May 2026: CASGEVY, ATSN-201 Data and More

Women’s Health Update – 13 May 2026: VEPPANU FDA Approval, POHERDY EU Approval and More

Neuroscience Update – 13 May 2026: Auvelity, Kisunla and More

Obesity Update – 12 May 2026: Eli Lilly GLP-1 Demand Surge, MariTide Switch Study and More

Artificial Intelligence and Digital Health Update – 12 May 2026: FDA AI, Roche-PathAI Deal and More

Oncology Update – 11 May 2026: VEPPANU Approval, Zipalertinib NDA and More

Public Health Update–8 May 2026: Pembrolizumab CRC durability, Argentina hantavirus outbreak & More

Rare Diseases Update – 7 May 2026: Intellia BLA, Tavneos Withdrawal and More

Cardiovascular Update – 7 May 2026: Aficamten Hits Endpoints, FDA Relay Pro Warning and More

Immunology Update – 6 May 2026: Rhapsido, Saphnelo Pen and More

Endocrinology Update – 5 May 2026: Tzield Pediatric Expansion, Semaglutide Teens Data and More

Hematology Update – 4 May 2026: Blenrep China Approval, Jakafi XR Approval and More

Respiratory Research Update – 30 Apr 2026: ENFLONSIA EU Approval, Breztri Asthma Approval and More

Vaccines Research Update – 30 Apr 2026: EU approval of flu-COVID vaccine, H5 Phase 3 advance & More

Gene and Cell Therapy Update – 30 Apr 2026: Otarmeni Approval, Kelonia Deal and More

Neuroscience Update – 29 Apr 2026: CAPLYTA sNDA, Itvisma CHMP and More

Women’s Health Update – 29 Apr 2026: Sun Pharma-Organon, Phase 3 Afuresertib and More

Obesity Update – 28 Apr 2026: Lilly Oral GLP-1 Launches, FDA Foundayo Safety and More

ARTIFICIAL INTELLIGENCE and DIGITAL HEALTH Update – 28 April 2026: GPT-Rosalind Launch and More

Oncology Update – 27 Apr 2026: Ifinatamab Priority Review, Ojemda EU Approval and More